Equities

Glaukos Corp

Glaukos Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)141.75
  • Today's Change2.42 / 1.74%
  • Shares traded681.59k
  • 1 Year change+120.86%
  • Beta1.0357
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

Glaukos Corp (GKOS:NYQ) set a new 52-week high during Friday's trading session when it reached 143.58. Over this period, the share price is up 123.26%.
52-week range
Today
59.22Nov 27 2023143.58Nov 08 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open139.02
High143.58
Low137.93
Bid141.05
Offer142.31
Previous close139.33
Average volume795.97k
Shares outstanding55.14m
Free float53.38m
P/E (TTM)--
Market cap7.82bn USD
EPS (TTM)-2.96
USD
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.